Your browser is no longer supported. Please, upgrade your browser.
Settings
BSX Boston Scientific Corporation daily Stock Chart
BSX [NYSE]
Boston Scientific Corporation
IndexS&P 500 P/E98.02 EPS (ttm)0.25 Insider Own0.30% Shs Outstand1.36B Perf Week2.32%
Market Cap33.58B Forward P/E17.43 EPS next Y1.42 Insider Trans-7.03% Shs Float1.35B Perf Month-0.44%
Income347.00M PEG7.87 EPS next Q0.30 Inst Own93.90% Short Float1.20% Perf Quarter13.25%
Sales8.39B P/S4.00 EPS this Y241.40% Inst Trans1.39% Short Ratio2.00 Perf Half Y4.09%
Book/sh4.94 P/B5.00 EPS next Y13.82% ROA1.90% Target Price28.07 Perf Year33.15%
Cash/sh0.14 P/C171.33 EPS next 5Y12.45% ROE5.40% 52W Range17.87 - 25.65 Perf YTD14.19%
Dividend- P/FCF72.37 EPS past 5Y-2.80% ROI5.10% 52W High-3.70% Beta1.11
Dividend %- Quick Ratio0.60 Sales past 5Y1.90% Gross Margin71.50% 52W Low38.22% ATR0.38
Employees27000 Current Ratio0.90 Sales Q/Q10.80% Oper. Margin5.30% RSI (14)55.44 Volatility1.49% 1.32%
OptionableYes Debt/Eq0.81 EPS Q/Q184.90% Profit Margin4.10% Rel Volume0.65 Prev Close24.58
ShortableYes LT Debt/Eq0.80 EarningsMay 04 BMO Payout0.00% Avg Volume8.12M Price24.70
Recom1.80 SMA200.60% SMA500.56% SMA2006.20% Volume5,243,865 Change0.49%
Feb-03-17Reiterated Needham Buy $28 → $29
Sep-01-16Upgrade Argus Hold → Buy
Jul-29-16Reiterated Wedbush Neutral $23 → $25
Jul-29-16Reiterated Needham Buy $26 → $28
Jul-28-16Reiterated The Benchmark Company Buy $25 → $31
Jun-09-16Initiated Guggenheim Buy
Apr-28-16Reiterated Wedbush Neutral $19 → $23
Apr-28-16Reiterated Stifel Buy $22 → $25
Apr-28-16Reiterated RBC Capital Mkts Outperform $22 → $25
Apr-28-16Reiterated Barclays Overweight $23 → $25
Apr-27-16Reiterated The Benchmark Company Buy $20 → $22
Apr-12-16Reiterated RBC Capital Mkts Outperform $20 → $22
Mar-17-16Initiated Nomura Buy
Feb-25-16Initiated Sun Trust Rbsn Humphrey Buy $21
Nov-12-15Initiated Citigroup Buy
Oct-28-15Reiterated Needham Buy $21 → $22
Oct-05-15Upgrade Raymond James Outperform → Strong Buy
Sep-28-15Upgrade Needham Hold → Buy $21
Aug-27-15Upgrade Goldman Neutral → Buy
Jul-23-15Reiterated The Benchmark Company Buy $19 → $20
Mar-28-17 08:09AM  Boston Scientific Corp. breached its 50 day moving average in a Bullish Manner : BSX-US : March 28, 2017
Mar-27-17 05:07PM  Medtronic, Edwards Among Five Best 'Stocks To Own': Analyst
Mar-17-17 04:32PM  Medtronic Does Heart-Valve Study, And Rivals Reap The Benefits
08:17AM  Boston Scientific Corp. breached its 50 day moving average in a Bearish Manner : BSX-US : March 17, 2017
Mar-16-17 09:16PM  NICE Recommends Boston Scientific CRT-D Devices Powered By EnduraLife Battery Technology For Treatment Of Heart Failure PR Newswire
Mar-13-17 04:36PM  U.S. medtech shares gain as investors seek shelter from drug price debate
Mar-10-17 02:29PM  German Court Rules In Favor Of Boston Scientific Corporation (BSX) In Patent Case Against Edwards Lifesciences Corp (EW) at Insider Monkey
09:25AM  Boston Scientific and Edwards Lifesciences Are in a Patent Battle
08:15AM  Blog Coverage German and UK Courts Rule in Favor of Boston Scientifics' Patent Related Litigation with Edwards Lifesciences Accesswire
Mar-09-17 04:49PM  Boston Scientific Wins In Patent Battle Vs. Edwards In German Court
04:59AM  Boston Scientific Receives Favorable Rulings In Edwards Lifesciences Litigation PR Newswire
Mar-07-17 08:30AM  Boston Scientific To Participate In Barclays Global Healthcare Conference PR Newswire
06:30AM  At Boston Scientific, device tax reprieve spurs mostly ex-U.S. job growth at bizjournals.com
Mar-03-17 07:00AM  Boston Scientific Announces Six Finalists in 2nd Annual Connected Patient Challenge, Focused on Healthcare Data Analytics PR Newswire
Mar-01-17 01:04PM  BOSTON SCIENTIFIC CORP Financials
Feb-24-17 01:03PM  Boston Scientific Corporation (BSX) Lotus Transcatheter Recalled After Discovery Of Fault And Death Of One Patient at Insider Monkey
11:15AM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Boston Scientific Corporation and Advises Investors with Losses to Contact the Firm Business Wire
11:10AM  Boston Scientific Recalls Lotus Heart Devices at Investopedia
10:30AM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Boston Scientific Corporation Investors Business Wire
Feb-23-17 11:59PM  [$$] Boston Scientific Recalls Lotus Heart Valve Device at The Wall Street Journal
11:25PM  Asian stocks fall amid Trump trade policy fears, strong yen AP
06:51PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Boston Scientific Corporation and Encourages Investors with Losses to Contact the Firm Business Wire
04:33PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Boston Scientific Corporation Investors Business Wire
04:09PM  Boston Topples On Heart Valve Bug; 'Woes' Boost Edwards, Medtronic
01:28PM  Boston Scientific sinks on heart valve system recall
12:58PM  [$$] Boston Scientific Recalls Lotus Heart Valve Device at The Wall Street Journal
12:29PM  SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Boston Scientific Corporation and Encourages Investors with Losses to Contact the Firm Business Wire
11:52AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Boston Scientific Corp. (BSX) PR Newswire
10:34AM  Boston Scientific shares sink after device pulled, lifting rival Edwards Lifesciences at MarketWatch
10:27AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corp. - BSX PR Newswire
08:58AM  Boston Scientific recalls all Lotus Valve heart devices
08:37AM  Boston Scientific sinks 8% after news of device malfunction prompting voluntary market removal at MarketWatch
08:17AM  BOSTON SCIENTIFIC CORP Files SEC form 8-K, Other Events
Feb-22-17 02:02PM  Boston Scientific Corporation (BSX) Loses On A $309M Appeal At US Supreme Court at Insider Monkey
Feb-21-17 04:17PM  Edwards' 'Restart' On CardiAQ Heart-Valve Sets Up 2018 Europe Launch: RBC
09:55AM  U.S. top court rejects Boston Scientific's patent licensing appeal Reuters
09:43AM  U.S. Supreme Court rejects Boston Scientific's patent licensing appeal Reuters
08:30AM  Boston Scientific to Participate in Cowen and Company 37th Annual Healthcare Conference PR Newswire
Feb-15-17 08:30AM  Boston Scientific to Participate in 2017 RBC Capital Markets Global Healthcare Conference PR Newswire
Feb-10-17 04:39PM  BOSTON SCIENTIFIC CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial
Feb-09-17 10:07AM  Executives Find This Toy Makers Shares Attractive After Stock Price Plunges, Plus Other Insider Trading at Insider Monkey
Feb-07-17 08:15AM  Post Earnings Coverage as Stryker's Revenue Gained 16.7% on Constant Currency Basis; Adjusted EPS Increased 14.1% Accesswire
Feb-06-17 01:50PM  ETFs with exposure to Boston Scientific Corp. : February 6, 2017
09:55AM  Boston Scientific Corp. :BSX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
Feb-03-17 01:37PM  Boston Scientific Corp. :BSX-US: Earnings Analysis: 2016 By the Numbers : February 3, 2017
11:52AM  Boston Scientific Corp. :BSX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 3, 2017
Feb-02-17 04:09PM  No "Sophomore Slump" Ahead For Boston Scientific at Barrons.com
03:10PM  Why the state's two biggest medical device firms have gained $4.5B in market cap this week at bizjournals.com
11:25AM  Edited Transcript of BSX earnings conference call or presentation 2-Feb-17 1:00pm GMT
11:22AM  Edwards Lifesciences Sinks 9%; Is This A Buying Opportunity? at Barrons.com
09:47AM  Boston Scientific (BSX) Tops Q4 Earnings, Offers 2017 View
08:11AM  Boston Scientific beats Street 4Q forecasts
08:03AM  Boston Scientific (BSX) Beats on Earnings & Revenues in Q4
07:07AM  Q4 2016 Boston Scientific Corp Earnings Release - Before Market Open
06:30AM  Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 PR Newswire
Feb-01-17 01:34PM  5 Stocks with Spectacular Earnings Charts
08:44AM  Medical Product Earnings Due on Feb 2: BDX, BSX, IDXX, ATHN
08:30AM  Boston Scientific To Participate In LEERINK Partners 6th Annual Global Healthcare Conference PR Newswire
Jan-29-17 01:09PM  5 Trade Ideas for Monday: Alcoa, Boston Scientific, Cerner, FedEx and Yum
Jan-20-17 04:17PM  BOSTON SCIENTIFIC CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jan-19-17 08:00AM  Will Boston Scientific (BSX) Pull a Surprise in Q4 Earnings?
Jan-17-17 08:09AM  Analysts' Actions -- Chipotle, Disney, Brinker, J.P. Morgan and More
Jan-11-17 09:28AM  Boston Scientific Charts Appear Boston Strong
Jan-08-17 11:54PM  Parkinsons Therapy Gets Fresh Look From Device Makers at The Wall Street Journal
11:47AM  Parkinson's Therapy Gets Fresh Look From Device Makers at The Wall Street Journal
Jan-04-17 10:35AM  A Look at Becton Dickinsons Recent Stock Performance
Jan-03-17 04:14PM  Medtronic Downgraded On Increased Boston, J&J, St. Jude Rivalries
10:36AM  A Look at BDXs Recent Product Launches
08:30AM  Boston Scientific To Webcast Conference Call Discussing Fourth Quarter 2016 Financial Results And Announces 2017 Investor Day Business Review PR Newswire
Dec-30-16 12:35PM  St. Judes Proclaim Elite SCS System Received CE Mark Approval
11:05AM  How FDA Approval of EnSite Precision Will Benefit St. Judes
08:30AM  Boston Scientific To Participate In 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-29-16 09:19PM  Boston Scientific, Google look to jumpstart digital health startups at bizjournals.com
Dec-27-16 10:24AM  Boston Scientific Corp. Value Analysis (NYSE:BSX) : December 27, 2016
07:49AM  Boston Scientific Down on Risks; Innovations Raise Hope
Dec-26-16 09:06AM  Medtronics CoreValve Evolut R Expands Its Global Access
Dec-23-16 07:08AM  Boston Scientific Corp. breached its 50 day moving average in a Bullish Manner : BSX-US : December 23, 2016
Dec-22-16 11:44AM  These Billionaire Michael Prices Stock Picks Can Destroy Your Portfolio at Insider Monkey
Dec-20-16 07:35AM  Inside Edwards Lifesciences Financial Guidance for 2017
Dec-19-16 09:05AM  Where Is EWs SHV Therapy Segment Headed after Disappointing 3Q16 Sales?
Dec-16-16 09:06AM  Inside Edwards Lifesciences THV Product Pipeline and Future Growth Estimates
07:36AM  Edwards Lifesciences Riding High on TAVR Sales Growth and Future Opportunities
Dec-15-16 01:54PM  The Word on the Street: What Analysts Are Recommending for Edwards Lifesciences Now
Dec-14-16 08:24AM  Boston Scientific Acquires Neovasc to Boost Heart Business
Dec-13-16 07:35AM  [$$] Is Boston Scientific Nervous About Nevro? at Barrons.com
07:00AM  Neovasc and Boston Scientific Close US$75 Million Agreement CNW Group
07:00AM  Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common Shares of Neovasc, Inc. PR Newswire
Dec-09-16 05:22PM  Nevro Announces Filing of Lawsuit by Boston Scientific PR Newswire
Dec-08-16 02:05PM  Edwards Heart-Valve Guidance Lags On Medtronic, Boston Rivalry
Dec-07-16 11:20AM  Boston Scientific Corporation -- Moody's upgrades Boston Scientific's senior unsecured rating to Baa2; outlook is stable at Moody's
Dec-06-16 04:53PM  Edwards 2017 Guidance Likely Hinges On Rivalry With Medtronic, Boston
Dec-05-16 08:25AM  Analysts' Actions -- Boston Scientific, McDonald's, National Beverage, More
08:10AM  Boston Scientific (BSX) Inks $75 Million Deal with Neovasc
Dec-04-16 03:24PM  Barclays PLC (ADR) (BCS): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-02-16 04:22PM  Boston Scientific Acquisition Eyes Rivals Edwards, Medtronic
11:44AM  Boston Scientific Acquisition Eyes Rivals Edwards, Medtronic
08:05AM  Boston Scientific Completes Its Acquisition of EndoChoice
07:00AM  Neovasc and Boston Scientific Reach US$75 Million Agreement CNW Group
07:00AM  Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities PR Newswire
Dec-01-16 11:05AM  Trial Data Affirms Positive Results of HeartLogic Diagnostic Service
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pierce David ASVP and President, EndoscopyMar 03Sale25.0125,012625,66825,600Mar 03 05:50 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMar 03Sale25.0123,540588,846245,846Mar 03 05:50 PM
Mackey Edward FEVP, OperationsMar 02Option Exercise0.0019,226037,058Mar 03 05:50 PM
Ballinger Kevin J.EVP & Pres, Interven CardioFeb 28Option Exercise0.005,7510101,143Mar 01 08:54 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 28Option Exercise0.003,3830219,923Mar 01 08:56 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 28Option Exercise0.003,383015,201Mar 01 08:55 PM
Brennan Daniel J.EVP and CFOFeb 28Option Exercise0.002,7060243,212Mar 01 08:55 PM
Bose SupratimEVP & President, Asia-PacificFeb 28Option Exercise0.006,7660320,301Mar 01 08:55 PM
Phalen Michael P.EVP & President, MedSurgFeb 28Option Exercise0.005,4130151,678Mar 01 08:56 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 28Option Exercise0.004,7360110,120Mar 02 07:17 PM
Mahoney Michael FChairman, President & CEOFeb 28Option Exercise0.0050,74402,013,705Mar 02 07:23 PM
Carruthers WendySVP, Human ResourcesFeb 28Option Exercise0.003,7210134,559Mar 02 07:21 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 28Option Exercise0.005,4130110,714Mar 02 07:29 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 28Option Exercise0.005,413025,749Mar 02 07:29 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 28Option Exercise0.008,4570294,948Mar 02 07:28 PM
Pierce David ASVP and President, EndoscopyFeb 28Option Exercise0.004,398064,794Mar 02 07:28 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 28Option Exercise0.006,0890166,059Mar 02 07:30 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 28Option Exercise0.003,7210114,505Mar 02 07:34 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 28Sale24.6430,000739,13468,165Mar 02 07:17 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 28Sale24.6725,000616,66378,675Mar 02 07:34 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 27Option Exercise0.004,3000106,247Feb 28 05:59 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 27Option Exercise0.007,166022,734Feb 28 05:59 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 27Option Exercise0.009,5550248,758Feb 28 05:59 PM
Pierce David ASVP and President, EndoscopyFeb 27Option Exercise0.003,185034,267Feb 28 05:58 PM
Mahoney Michael FChairman, President & CEOFeb 27Option Exercise0.0057,32501,699,415Feb 28 05:58 PM
Carruthers WendySVP, Human ResourcesFeb 27Option Exercise0.004,6180107,491Feb 28 05:58 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 27Option Exercise0.002,548012,996Feb 28 05:57 PM
Brennan Daniel J.EVP and CFOFeb 27Option Exercise0.002,5880184,386Feb 28 05:57 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 27Sale24.844,832120,034240,621Feb 28 05:59 PM
Pierce David ASVP and President, EndoscopyFeb 27Sale24.843,41784,88329,816Feb 28 05:58 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 24Option Exercise0.002,293080,086Feb 27 04:28 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 24Option Exercise0.004,7780109,829Feb 27 04:28 PM
Mahoney Michael FChairman, President & CEOFeb 24Option Exercise0.0029,05201,655,759Feb 27 04:29 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 24Option Exercise0.002,485085,187Feb 27 04:29 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 24Option Exercise0.002,6760189,297Feb 27 04:29 PM
Bose SupratimEVP & President, Asia-PacificFeb 24Option Exercise0.002,6760283,592Feb 27 04:27 PM
Brennan Daniel J.EVP and CFOFeb 24Option Exercise0.005,7340183,958Feb 27 04:27 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 24Option Exercise0.001,338011,114Feb 27 04:27 PM
Carruthers WendySVP, Human ResourcesFeb 24Option Exercise0.002,4850103,680Feb 27 04:28 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 24Option Exercise0.002,867065,574Feb 27 04:27 PM
Phalen Michael P.EVP & President, MedSurgFeb 24Option Exercise0.003,4400108,678Feb 27 04:30 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 24Option Exercise0.004,5870240,692Feb 27 05:29 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 24Option Exercise0.001,5290102,284Feb 27 05:29 PM
Pierce David ASVP and President, EndoscopyFeb 24Option Exercise0.003,058032,075Feb 27 05:28 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 24Option Exercise0.001,529016,068Feb 27 05:29 PM
Phalen Michael P.EVP & President, MedSurgFeb 23Option Exercise0.002,4520106,034Feb 24 05:22 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 23Option Exercise0.009190100,958Feb 24 05:21 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 23Option Exercise0.001,533015,121Feb 24 05:21 PM
Pierce David ASVP and President, EndoscopyFeb 23Option Exercise0.002,452029,813Feb 24 04:28 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 23Option Exercise0.003,6780237,299Feb 24 04:28 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 23Option Exercise0.002,146083,424Feb 24 04:22 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 23Option Exercise0.001,8390187,313Feb 24 04:22 PM
Mahoney Michael FChairman, President & CEOFeb 23Option Exercise0.0023,75801,637,886Feb 24 04:21 PM
Mackey Edward FEVP, OperationsFeb 23Option Exercise0.002,299018,559Feb 24 04:20 PM
Carruthers WendySVP, Human ResourcesFeb 23Option Exercise0.002,4520101,991Feb 24 04:19 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 23Option Exercise0.004,1380106,442Feb 24 04:20 PM
Brennan Daniel J.EVP and CFOFeb 23Option Exercise0.005,3650179,965Feb 24 04:19 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 23Option Exercise0.001,073010,338Feb 24 04:19 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 23Option Exercise0.001,839078,624Feb 24 04:19 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 23Option Exercise0.003,678063,943Feb 24 04:18 PM
Bose SupratimEVP & President, Asia-PacificFeb 23Option Exercise0.002,1460280,916Feb 24 04:18 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 22Option Exercise0.001,8820186,182Feb 23 06:41 PM
Phalen Michael P.EVP & President, MedSurgFeb 22Option Exercise0.002,4620104,381Feb 23 06:41 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 22Option Exercise0.001,01309,796Feb 23 06:40 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 22Option Exercise0.004,0550103,667Feb 23 06:40 PM
Carruthers WendySVP, Human ResourcesFeb 22Option Exercise0.002,3170100,291Feb 23 05:21 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 22Option Exercise0.001,738077,602Feb 23 05:24 PM
Brennan Daniel J.EVP and CFOFeb 22Option Exercise0.005,7930176,480Feb 23 05:10 PM
Bose SupratimEVP & President, Asia-PacificFeb 22Option Exercise0.002,1720278,770Feb 23 05:05 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 22Option Exercise0.003,765061,531Feb 23 05:00 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 22Option Exercise0.002,0270100,485Feb 23 06:43 PM
Pierce David ASVP and President, EndoscopyFeb 22Option Exercise0.002,607028,207Feb 23 06:42 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 22Option Exercise0.003,4760234,749Feb 23 06:42 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 22Option Exercise0.001,593014,208Feb 23 06:42 PM
Mackey Edward FEVP, OperationsFeb 22Option Exercise0.002,896017,302Feb 23 06:41 PM
Mahoney Michael FChairman, President & CEOFeb 22Option Exercise0.0023,17401,625,032Feb 23 06:41 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 22Option Exercise0.002,317082,057Feb 23 06:41 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 07Sale25.2180,7832,036,52375,864Feb 08 04:24 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 06Sale24.9423,775592,85898,458Feb 08 04:24 PM
Pierce David ASVP and President, EndoscopyJan 09Sale22.2410,232227,54625,600Jan 10 04:08 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJan 09Sale22.246,195137,769231,273Jan 10 04:06 PM
Bose SupratimEVP & President, Asia-PacificJan 03Option Exercise0.0014,9260276,598Jan 05 05:07 PM
Phalen Michael P.EVP & President, MedSurgJan 01Option Exercise0.0017,5100107,596Jan 04 04:40 PM
Pierce David ASVP and President, EndoscopyJan 01Option Exercise0.0015,565041,165Jan 04 04:40 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJan 01Option Exercise0.0023,3470245,326Jan 04 04:40 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventJan 01Option Exercise0.0012,646084,271Jan 04 04:30 PM
Nanavaty MaulikSVP & Pres, NeuromodulationJan 01Option Exercise0.0013,6190189,746Jan 04 04:30 PM
Mahoney Michael FPresident & CEOJan 01Option Exercise0.00147,87301,664,964Jan 04 04:26 PM
Carruthers WendySVP, Human ResourcesJan 01Option Exercise0.0012,6460102,360Jan 04 04:19 PM
Ballinger Kevin J.SVP & Pres, Interven CardioJan 01Option Exercise0.0014,592062,951Jan 04 04:13 PM
Bose SupratimEVP & President, Asia-PacificJan 01Option Exercise0.0013,6190261,672Jan 04 04:13 PM
Brennan Daniel J.EVP and CFOJan 01Option Exercise0.0029,1850180,439Jan 04 04:14 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerDec 01Option Exercise13.5618,761254,399260,430Dec 05 04:07 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeDec 01Option Exercise0.002,3270122,745Dec 05 04:07 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerDec 01Sale20.4826,726547,367233,704Dec 05 04:07 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerNov 01Option Exercise13.5617,000230,520266,421Nov 03 04:50 PM
Mahoney Michael FPresident & CEONov 01Option Exercise0.00341,67001,677,847Nov 03 04:54 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerNov 01Sale21.8924,752541,826241,669Nov 03 04:50 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeOct 29Option Exercise0.001,6960120,792Nov 01 04:09 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeOct 25Option Exercise0.003,6900119,908Oct 27 04:40 PM